Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.77 - $4.63 $54,422 - $90,965
19,647 New
19,647 $55,000
Q1 2023

May 15, 2023

BUY
$2.45 - $4.22 $5,791 - $9,976
2,364 Added 22.25%
12,990 $54,000
Q4 2022

Feb 14, 2023

SELL
$2.12 - $2.86 $15,268 - $20,597
-7,202 Reduced 40.4%
10,626 $29,000
Q3 2022

Nov 14, 2022

BUY
$2.33 - $3.92 $5,592 - $9,408
2,400 Added 15.56%
17,828 $46,000
Q2 2022

Aug 15, 2022

BUY
$3.28 - $6.42 $50,603 - $99,047
15,428 New
15,428 $56,000
Q1 2022

May 16, 2022

SELL
$5.16 - $7.14 $69,128 - $95,654
-13,397 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$6.37 - $8.18 $5,236 - $6,723
822 Added 6.54%
13,397 $94,000
Q3 2021

Nov 15, 2021

SELL
$6.98 - $8.47 $79,460 - $96,422
-11,384 Reduced 47.51%
12,575 $88,000
Q2 2021

Aug 16, 2021

SELL
$5.44 - $8.4 $50,037 - $77,263
-9,198 Reduced 27.74%
23,959 $200,000
Q1 2021

May 17, 2021

BUY
$3.91 - $6.99 $129,643 - $231,767
33,157 New
33,157 $181,000
Q4 2020

Feb 16, 2021

SELL
$3.0 - $4.5 $74,256 - $111,384
-24,752 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$2.75 - $4.2 $68,068 - $103,958
24,752 New
24,752 $75,000
Q2 2020

Aug 14, 2020

SELL
$2.12 - $3.14 $41,333 - $61,220
-19,497 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$1.42 - $3.29 $68,219 - $158,058
-48,042 Reduced 71.13%
19,497 $43,000
Q4 2019

Feb 14, 2020

BUY
$2.45 - $3.25 $126,907 - $168,346
51,799 Added 329.09%
67,539 $206,000
Q3 2019

Nov 14, 2019

SELL
$1.59 - $3.47 $161,095 - $351,573
-101,318 Reduced 86.55%
15,740 $48,000
Q2 2019

Aug 14, 2019

BUY
$1.93 - $4.59 $122,392 - $291,079
63,416 Added 118.22%
117,058 $234,000
Q1 2019

May 15, 2019

SELL
$2.77 - $4.38 $121,741 - $192,501
-43,950 Reduced 45.03%
53,642 $231,000
Q4 2018

Feb 14, 2019

BUY
$3.03 - $5.0 $125,729 - $207,475
41,495 Added 73.97%
97,592 $310,000
Q3 2018

Nov 14, 2018

BUY
$5.0 - $6.65 $223,940 - $297,840
44,788 Added 396.04%
56,097 $295,000
Q2 2018

Aug 14, 2018

BUY
$4.2 - $5.95 $47,497 - $67,288
11,309 New
11,309 $61,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $90.4M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.